BOSTON - Beth Israel Deaconess Medical Center has once again been named to US News & World Report's list as a leading hospital in Boston and in the nation, one of just 148 of approximately 5,000 hospitals that performed well enough to rank in even one specialty.
The recognition is the latest in a series of high-visibility honors for BIDMC, which was cited as the top hospital in Massachusetts - and one of only 65 in the nation - by the
Leapfrog Group, which focuses on patient safety and quality. That recognition was the fifth in six years.
And for the 10th time - and the sixth in seven years - BIDMC was named one of the
Top 100 Hospitals in the United States based in overall organizational performance, the only Boston hospital cited in the annual study released by Thomson Reuters.
In US News & World Report, BIDMC is ranked in the Top 50 in three clinical specialty categories: cancer; gastroenterology and diabetes and endocrinology - a ranking shared with the Joslin Diabetes Center.
BIDMC was also ranked as "high-performing" in eight additional specialties, including cardiology and heart surgery; ears, nose and throat; geriatrics; gynecology; nephrology; neurology/neurosurgery, pulmonology and urology.
The magazine also ranked BIDMC as No. 3 in both Boston and Massachusetts.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently
ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit